- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genus PLC (GNS)
The Genus share price today is 2,320.0, view LON GNS stock exchange data. Track the latest Genus share price with real-time updates on GNS stock performance including market cap, day range, 52-week range and dividend yield. Access GNS charts, earnings dates and analyst estimates to support your investment decisions.
2,320.0
-36.0(-1.53%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,312.0
2,356.0
52 wk Range
1,890.0
3,220.0
GNS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2,312.02,356.0
52 wk Range
1,890.03,220.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.40%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.40%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
GNS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
3,128.2
Upside
+34.83%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Genus receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Genus receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Genus receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Genus receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Genus receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
9 Buy
3 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3,128.2
(+34.83% Upside)
Genus PLC Earnings Call Summary for H1/2026
- Genus PLC reported 57% profit before tax increase to £55.7M and 53% EPS growth to 60.8p, despite flat revenue in H1 FY2026.
- Stock declined 7.89% in early trading amid investor concerns over operational challenges and market conditions.
- PRRS-resistant pig technology received Canadian regulatory approval; awaiting clearance in Mexico and Japan for commercialization.
- Company forecasts stronger H2 free cash flow, targeting 70% cash conversion and full-year FCF exceeding FY2025 levels.
- Interim dividend raised to 11.2p from 10.3p; challenges include weak Chinese pork prices and U.S. bovine genetics border closure.
Last Updated: 26-02-2026, 03:24 pm
Read Full TranscriptEarnings
Latest Release
26-02-2026
EPS / Forecast
0.60 / --
Revenue / Forecast
335.6M / --
Compare GNS to Peers and Sector
Metrics to compare | GNS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGNSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 33.5x | −6.7x | −0.5x | |
PEG Ratio | 0.03 | −0.02 | 0.00 | |
Price/Book | 3.2x | 3.3x | 2.6x | |
Price / LTM Sales | 2.4x | 6.3x | 3.2x | |
Upside (Analyst Target) | 34.7% | 82.3% | 47.8% | |
Fair Value Upside | Unlock | −0.7% | 5.9% | Unlock |
Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Genus (GNS) Share Price Today?
The Genus share price today is 2,320.0.
What is the current Genus (GNS) share price and day range?
As of 09-05-2026, the Genus share price is 2,320.0, with a previous close of 2,356.0. The share price has ranged from 2,312.0 to 2,356.0 today, while the 52-week range spans from 1,890.0 to 3,220.0.
What Is the Genus Market Cap?
As of today, Genus market cap is 1.55B.
Does Genus Pay Dividends? What's The Current Dividend Yield?
The Genus dividend yield is 1.4%.
What Is the Genus (GNS) Share Price Target?
The average 12-month share price target for Genus is 3,128.2, with a high estimate of 3700 and a low estimate of 2550. 9 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +34.83% Upside potential.
What Is Genus's Earnings Per Share (TTM)?
The Genus EPS (TTM) is 0.7.
When Is the Next Genus Earnings Date?
Genus will release its next earnings report on 26-02-2026.
From a Technical Analysis Perspective, Is GNS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Genus Trade On?
Genus is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Genus?
The stock symbol for Genus is "GNS."
How Many Times Has Genus Stock Split?
Genus has split 0 times.
How Many Employees Does Genus Have?
Genus has 3190 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.